This compound is a secondary carboxamide formed from piperidine-4-carboxylic acid and a substituted thiazole-amine. It acts as an ATP-competitive inhibitor of CDK2, CDK7, and CDK9 kinases and has shown anti-cancer properties in research studies.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 345627-80-7
Ketotifen fumarate
pharmaceutical raw material
Amoxicillin sodium
pharmaceutical raw material
Urapidil
pharmaceutical raw material
Alloferon
pharmaceutical raw material
N-[5-[(5-tert-butyl-1,3-oxazol-2-yl)methylsulfanyl]-1,3-thiazol-2-yl]piperidine-4-carboxamide
OUSFTKFNBAZUKL-UHFFFAOYSA-N
CC(C)(C)C1=CN=C(O1)CSC2=CN=C(S2)NC(=O)C3CCNCC3